
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1441674-54-9 |
| Catalog No. | 2A-1168273 |
| Chinese Name | 雷迪帕韦单丙酮溶剂化物 |
| Synonyms | Ledipasvir (acetone); Ledipasvir (GS5885) acetone |
| Molecular Formula | C52H60F2N8O7 |
| Molecular Weight | 947.079 |
| Storage Condition | 2-8℃ |
| Application | Ledipasvir acetone is the active pharmaceutical ingredient of Ledipasvir. Ledipasvir is a potent inhibitor of hepatitis C virus NS5A and can inhibit GT1a and GT1b replicon activities with EC50 values |
| PubChem ID | 210275259 |
| InChI | InChI=1S/C49H54F2N8O6.C3H6O/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6;1-3(2)4/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63);1-2H3/t29-,30+,38-,39-,40-,41-;/m0./s1 |
| InChI Key | FJPWYOHJVGOKNZ-NDANSHMASA-N |
| Transport Info | Product Name: Ledipasvir Acetone |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Upadacitinib ABT 494 N-8 Intermediates | 55314-57-3 | 2A-1167607 |
| Olmesartan-API | 2A-1167664 | 2A-1167664 |
| N-acylamino linagliptin-((1-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)urea)) | 2A-1167671 | 2A-1167671 |
| Efavirenz Enantiomer- (4R)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one | 154801-74-8 | 2A-1167912 |
| 2-AMino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetaMide (ClonazepaM IMpurity) | 17714-02-2 | 2A-1168070 |
| Ledipasvir interMediate | 1256388-50-7 | 2A-1168275 |
| ledipasvir interMediate | 1441670-89-8 | 2A-1168276 |
| ledipasvir interMediate | 1256387-87-7 | 2A-1168277 |
| Pantoprazole sodium sesquihydrate | 164579-32-2 | 2A-4168297 |
| 6-beta-Fluoro-triamcinolone-acetonide Acetate | 67438-37-3 | 2A-1168310 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA